iTeos Therapeutics, Inc. (ITOS) has a market capitalization of $448.68M and trades at $10.15. The 52-week range is 4.8-17.63.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -3.1, Earnings Per Share (EPS) of $-3.32, annual revenue of $35M.
The stock has a beta of 1.49, operates in the Healthcare sector.
